While many modifications are not functionally validated, cysteine mutants such as those used by Mills et al. (KEAP1 mutants; ref. 11) and Liao et al. (GAPDH mutants; ref. 78) are able to demonstrate which cysteine modifications may have functional importance in the context of OI. Here, KEAP1 is linked to osteogenesis imperfecta.